Armata Pharmaceuticals (ARMP) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $3.37, +9.06% vs the prior close of $3.09.
- Volume 154.31K shares, 0.7x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ARMP jumps 9.1% to $3.37. Closed at $3.37, +9.06% vs the prior close of $3.09. Day range $3.01–$3.42, opened at $3.08.
ARMP daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — ARMP jumps 9.1% to $3.37
- Closed at $3.37, +9.06% vs the prior close of $3.09. Day range $3.01–$3.42, opened at $3.08.
- Volume was 154.31K shares, 0.7x its 50-day average of 214.70K.
- Price is -24.0% vs its 50-day average ($4.44) and -53.0% vs its 200-day average ($7.18).
- 52-week range $2.75–$16.34; today's close sits at 5% of that range, 79.4% below the 52-week high.
Oct 15, 2026 — ARMP jumps 11.2% to $3.09
- Closed at $3.09, +11.15% vs the prior close of $2.78. Day range $2.83–$3.16, opened at $2.86.
- Volume was 115.70K shares, 0.5x its 50-day average of 214.46K — lighter than usual.
- Price is -30.8% vs its 50-day average ($4.46) and -57.0% vs its 200-day average ($7.19).
- 52-week range $2.75–$16.34; today's close sits at 3% of that range, 81.1% below the 52-week high.
Oct 14, 2026 — ARMP slides 10.3% to $2.78, a 52-week low, 4 down days in a row
- Closed at $2.78, -10.32% vs the prior close of $3.10. Day range $2.75–$3.06, opened at $3.06.
- Volume was 125.50K shares, 0.6x its 50-day average of 217.47K — lighter than usual.
- Price is -38.1% vs its 50-day average ($4.49) and -61.4% vs its 200-day average ($7.21).
- 52-week range $2.75–$16.34; today's close sits at 0% of that range, 83.0% below the 52-week high.
- That makes 4 straight losses.
Oct 13, 2026 — ARMP slides 14.6% to $3.10, a 52-week low, 3 down days in a row
- Closed at $3.10, -14.60% vs the prior close of $3.63. Day range $3.01–$3.68, opened at $3.68.
- Volume was 223.20K shares, 1.0x its 50-day average of 214.21K.
- Price is -31.6% vs its 50-day average ($4.53) and -57.1% vs its 200-day average ($7.23).
- 52-week range $3.01–$16.34; today's close sits at 1% of that range, 81.0% below the 52-week high.
- That makes 3 straight losses.
Oct 12, 2026 — ARMP ends flat (+0.0%) to $3.63
- Closed at $3.63, +0.00% vs the prior close of $3.63. Day range $3.56–$3.84, opened at $3.65.
- Volume was 45.90K shares, 0.2x its 50-day average of 213.91K — lighter than usual.
- Price is -20.6% vs its 50-day average ($4.57) and -49.9% vs its 200-day average ($7.24).
- 52-week range $3.14–$16.34; today's close sits at 4% of that range, 77.8% below the 52-week high.
Oct 9, 2026 — ARMP slides 6.0% to $3.63
- Closed at $3.63, -5.96% vs the prior close of $3.86. Day range $3.62–$3.95, opened at $3.90.
- Volume was 100.60K shares, 0.5x its 50-day average of 213.18K — lighter than usual.
- Price is -20.9% vs its 50-day average ($4.59) and -50.0% vs its 200-day average ($7.25).
- 52-week range $3.09–$16.34; today's close sits at 4% of that range, 77.8% below the 52-week high.
Oct 8, 2026 — ARMP rises 1.3% to $3.86
- Closed at $3.86, +1.31% vs the prior close of $3.81. Day range $3.59–$3.91, opened at $3.79.
- Volume was 70.30K shares, 0.3x its 50-day average of 213.72K — lighter than usual.
- Price is -16.3% vs its 50-day average ($4.61) and -46.9% vs its 200-day average ($7.27).
- 52-week range $3.09–$16.34; today's close sits at 6% of that range, 76.4% below the 52-week high.
Oct 7, 2026 — ARMP dips 1.0% to $3.81
- Closed at $3.81, -1.04% vs the prior close of $3.85. Day range $3.72–$4.07, opened at $3.83.
- Volume was 103.60K shares, 0.5x its 50-day average of 212.83K — lighter than usual.
- Price is -17.7% vs its 50-day average ($4.63) and -47.7% vs its 200-day average ($7.28).
- 52-week range $3.09–$16.34; today's close sits at 5% of that range, 76.7% below the 52-week high.
Oct 6, 2026 — ARMP jumps 5.2% to $3.85, 3 up days in a row
- Closed at $3.85, +5.19% vs the prior close of $3.66. Day range $3.66–$3.93, opened at $3.69.
- Volume was 114.60K shares, 0.5x its 50-day average of 212.46K — lighter than usual.
- Price is -17.1% vs its 50-day average ($4.65) and -47.2% vs its 200-day average ($7.29).
- 52-week range $3.08–$16.34; today's close sits at 6% of that range, 76.4% below the 52-week high.
- That makes 3 straight gains.
Oct 5, 2026 — ARMP jumps 4.0% to $3.66
- Closed at $3.66, +3.98% vs the prior close of $3.52. Day range $3.51–$3.68, opened at $3.54.
- Volume was 56.60K shares, 0.3x its 50-day average of 212.59K — lighter than usual.
- Price is -21.7% vs its 50-day average ($4.67) and -49.8% vs its 200-day average ($7.30).
- 52-week range $3.08–$16.34; today's close sits at 4% of that range, 77.6% below the 52-week high.
Oct 2, 2026 — ARMP jumps 6.3% to $3.52
- Closed at $3.52, +6.34% vs the prior close of $3.31. Day range $3.32–$3.55, opened at $3.40.
- Volume was 124.50K shares, 0.6x its 50-day average of 212.15K — lighter than usual.
- Price is -25.0% vs its 50-day average ($4.69) and -51.8% vs its 200-day average ($7.31).
- 52-week range $2.94–$16.34; today's close sits at 4% of that range, 78.5% below the 52-week high.
ARMP latest news & SEC filings
Every SEC filing by or about ARMP in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 23, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 12, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: $74.14M (prior year -$16.30M) (swung to profit vs Jun 30, 2025)
- Diluted EPS: -$0.27 (prior year -$0.45) (loss narrowed vs Jun 30, 2025)
Aug 12, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 20, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jul 20, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Jul 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jul 13, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Jun 24, 2026 · Form 8-K/A — Current report (amended)
Amended current report
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Jun 23, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Things to know before you trade ARMP
- Last results release: Aug 12, 2026 (8-K Item 2.02). Previous ones: May 13, 2026, Mar 25, 2026, Nov 12, 2025. Based on that rhythm, the next report is likely around Nov 11, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 5.38% (largest 14.6%). That is a volatile stock.
- Liquidity: about 117.95K shares (≈$397.49K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $3.37 vs a range of $2.75–$16.34 (5% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Sep 23, 2026; 8-K Sep 14, 2026; 10-Q Aug 12, 2026.
- Share count: 37.18M shares outstanding (Aug 6, 2026), +2.6% vs a year earlier.
- Listing: NYSE · industry: Biological Products, (No Diagnostic Substances).
ARMP market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 3.08 | 3.42 | 3.01 | 3.37 | 154.31K |
| Oct 15, 2026 | 2.86 | 3.16 | 2.83 | 3.09 | 115.70K |
| Oct 14, 2026 | 3.06 | 3.06 | 2.75 | 2.78 | 125.50K |
| Oct 13, 2026 | 3.68 | 3.68 | 3.01 | 3.10 | 223.20K |
| Oct 12, 2026 | 3.65 | 3.84 | 3.56 | 3.63 | 45.90K |
| Oct 9, 2026 | 3.90 | 3.95 | 3.62 | 3.63 | 100.60K |
| Oct 8, 2026 | 3.79 | 3.91 | 3.59 | 3.86 | 70.30K |
| Oct 7, 2026 | 3.83 | 4.07 | 3.72 | 3.81 | 103.60K |
| Oct 6, 2026 | 3.69 | 3.93 | 3.66 | 3.85 | 114.60K |
| Oct 5, 2026 | 3.54 | 3.68 | 3.51 | 3.66 | 56.60K |
| Oct 2, 2026 | 3.40 | 3.55 | 3.32 | 3.52 | 124.50K |
| Oct 1, 2026 | 3.67 | 3.78 | 3.28 | 3.31 | 76.40K |
| Sep 30, 2026 | 3.57 | 3.74 | 3.53 | 3.67 | 127.00K |
| Sep 29, 2026 | 3.74 | 3.74 | 3.52 | 3.59 | 91.80K |
| Sep 28, 2026 | 3.66 | 3.85 | 3.55 | 3.78 | 85.70K |
| Sep 25, 2026 | 3.60 | 3.81 | 3.56 | 3.74 | 100.80K |
| Sep 24, 2026 | 3.70 | 3.83 | 3.53 | 3.62 | 144.40K |
| Sep 23, 2026 | 4.20 | 4.30 | 3.60 | 3.64 | 286.90K |
| Sep 22, 2026 | 4.27 | 4.56 | 4.14 | 4.20 | 128.30K |
| Sep 21, 2026 | 4.24 | 4.36 | 4.10 | 4.26 | 82.90K |
About Armata Pharmaceuticals
Armata Pharmaceuticals (ARMP) is listed on the NYSE and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in LOS ANGELES, CA. State of incorporation: WA. Fiscal year ends December 31. SEC CIK 921114.
ARMP board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Deborah Birx | Chief Executive Officer | Jul 14, 2026 |
| Daniel B. Gilmer | Director | Apr 28, 2026 |
| Jules Haimovitz | Director | Mar 11, 2026 |
| Robin Kramer | Director | Mar 11, 2026 |
| Kostas D Odysseas | Director | Mar 11, 2026 |
| Joseph M Patti | Director | Mar 11, 2026 |
| Todd C. Peterson | Director | Mar 11, 2026 |
| Sarah J. Schlesinger | Director | Mar 11, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Deborah Birx | Chief Executive Officer | Jul 14, 2026 |
| David Duane House | SVP, Finance, and PFO | Mar 11, 2026 |
| Pierre Kyme | Chief Business Officer | Mar 17, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
ARMP financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-173.80M | -4.80 | $-25.76M |
| Dec 31, 2024 | — | $-18.92M | -0.89 | $-37.55M |
| Dec 31, 2023 | — | $-69.05M | -1.91 | $-47.42M |
| Dec 31, 2022 | — | $-36.92M | -1.08 | $-32.48M |
| Dec 31, 2021 | — | $-23.16M | -0.96 | $-23.57M |
Latest balance sheet: total assets $89.95M, total liabilities $321.12M, cash $23.95M (as of Jun 30, 2026).
ARMP earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 12, 2026 | 8-K Item 2.02 (results) | $4.31 |
| May 13, 2026 | 8-K Item 2.02 (results) | $8.82 |
| Mar 25, 2026 | 8-K Item 2.02 (results) | $8.61 |
| Nov 12, 2025 | 8-K Item 2.02 (results) | $6.69 |
| Aug 12, 2025 | 8-K Item 2.02 (results) | $2.46 |
| May 14, 2025 | 8-K Item 2.02 (results) | $1.38 |
| Mar 21, 2025 | 8-K Item 2.02 (results) | $1.79 |
| Nov 13, 2024 | 8-K Item 2.02 (results) | $2.72 |
| Aug 13, 2024 | 8-K Item 2.02 (results) | — |
| May 7, 2024 | 8-K Item 2.02 (results) | — |
| Mar 21, 2024 | 8-K Item 2.02 (results) | — |
| Nov 14, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Greenland Mines (GRML)Halozyme Therapeutics (HALO)Biogen (BIIB)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ARMP
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.